HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PALI
Palisade Bio, Inc.
There isn't enough reported data to score PALI yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PALI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Weak | |
| Unavailable |
PALI's profitability and cash flow are currently under pressure. There isn't enough data to rate its revenue and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PALI PE Valuation
PALI has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PALI Forward outlook
There aren't enough analyst estimates for PALI to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
PALI has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus PALI down 116%.
PALI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$13.83 | +$71.28 |
| Q2 2024 | -$18.86 | +$118.90 |
| Q1 2024 | -$23.49 | +$196.32 |
| Q4 2023 | -$27.00 | +$328.85 |
| Q3 2023 | -$85.11 | -116% |
| Q2 2023 | -$137.76 | -115% |
| Q1 2023 | -$219.81 | +$1,874.33 |
| Q4 2022 | -$355.85 | +$2,186.65 |
PALI lost $13.83 per share over the past year, a smaller loss than the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over PALI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over PALI on profitability, with a higher operating margin.
PALI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2020 | $2.5K | 0% |
PALI's revenue is growing: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2340% | N/A |
| Q1 2023 | -1012% | N/A |
| Q4 2020 | -175764% | -90461 points |
| Q3 2020 | -93745% | N/A |
| Q2 2020 | -77894% | N/A |
| Q1 2020 | -33064% | N/A |
| Q4 2019 | -85303% | N/A |
PALI's operating margin was −2340% last quarter, up 75555 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over PALI on cash generation, producing positive trailing cash flow while its opponent burns cash.
PALI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.8M | -$8.2M |
| Q2 2026 | -$7.6M | -$5.8M |
| Q1 2026 | -$3.9M | -$1.6M |
| Q4 2025 | -$3.1M | -$763K |
| Q3 2025 | -$3.6M | -$420K |
| Q1 2025 | -$2.3M | +$847K |
| Q4 2024 | -$2.4M | +$365K |
| Q3 2024 | -$3.1M | -$471K |
PALI has burned cash in almost every quarter: −$26M over the past year, against −$10M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over PALI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PALI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +646K shares |
| 1 year | +4320% | +207M shares |
| 3 years | +73597% | +212M shares |
| 5 years | +6879452% | +212M shares |
PALI has 212M diluted shares, up 4320% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PALI Net Leverage
PALI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PALI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 4.9 | Oversold |
PALI's weekly RSI is 33 (neutral) and its Stochastic is 5 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PALI PE vs Healthcare Sector
PALI has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PALI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 14% below |
| 20 week MA | $1.73 | 34% below |
| 50 week MA | $1.82 | 37% below |
| 100 week MA | $1.47 | 22% below |
| 200 week MA | $7.14 | 84% below |
PALI is in a downtrend: it's below all five of its weekly moving averages, and 84% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over PALI on returns for 2026, with the stronger performance.
PALI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4,103.9 | $4,025.6 | -1.9% |
| 2021 | $4,025.6 | $1,252.5 | -69% |
| 2022 | $1,252.5 | $28.7 | -98% |
| 2023 | $28.7 | $8.85 | -69% |
| 2024 | $8.85 | $1.67 | -81% |
| 2025 | $1.67 | $2.15 | +29% |
| 2026 YTD | $2.15 | $1.14 | -47% |
PALI has finished lower in five of the last six years. It's down 47% so far in 2026.